The discrepancies may be attributed to the limitations of BMI as a lone evaluator of metabolic disorders
Let me break down who qualifies and how it works
found in their study that in clear cell renal cell carcinoma (ccRCC) tumor cells, endogenous Gln metabolism might reduce the anti-tumor effectiveness of T cells by promoting the Treg cell response ( 2.1.4 Regulation of tumor cell redox homeostasis Gln regulates the redox status of cancer cells by influencing the production of mitochondrial ROS
Benefits are observed across the spectrum of cardiometabolic disease, including individuals with type 2 diabetes, CKD, and ASCVD [6, 14, 41, 42]
Lindeman, Low blood glutathione levels in healthy aging adults , Journal of Laboratory and Clinical Medicine, 120 (5), 1992, s
Bonakdar MA, Macromol DR, and undefined 2024, Electrospinning: Processes, structures, and materials, mdpi.com , [Online]